Clinical Trial Update: A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is studying cancer-related fatigue in patients with metastatic cancer treated with anti-PD-1 immunotherapy. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm | Phase 3 | Status: ACTIVE_NOT_RECRUITING